The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 24, 2009
Filed:
Aug. 18, 2006
Bruce Lester Banner, Wayne, NJ (US);
Joseph Anthony Bilotta, Astoria, NY (US);
Nader Fotouhi, Basking Ridge, NJ (US);
Paul Gillespie, Westfield, NJ (US);
Robert Alan Goodnow, Jr., Gillette, NJ (US);
Matthew Michael Hamilton, Hackettstown, NJ (US);
Nancy-ellen Haynes, Cranford, NJ (US);
Agnieszka Kowalczyk, Mine Hill, NJ (US);
Alexander Mayweg, Loerrach, DE;
Michael Paul Myers, Ramsey, NJ (US);
Sherrie Lynn Pietranico-cole, Montclair, NJ (US);
Nathan Robert Scott, Livingston, NJ (US);
Kshitij Chhabilbhai Thakkar, Clifton, NJ (US);
Jefferson Wright Tilley, North Caldwell, NJ (US);
Kevin Richard Guertin, Verona, NJ (US);
Bruce Lester Banner, Wayne, NJ (US);
Joseph Anthony Bilotta, Astoria, NY (US);
Nader Fotouhi, Basking Ridge, NJ (US);
Paul Gillespie, Westfield, NJ (US);
Robert Alan Goodnow, Jr., Gillette, NJ (US);
Matthew Michael Hamilton, Hackettstown, NJ (US);
Nancy-Ellen Haynes, Cranford, NJ (US);
Agnieszka Kowalczyk, Mine Hill, NJ (US);
Alexander Mayweg, Loerrach, DE;
Michael Paul Myers, Ramsey, NJ (US);
Sherrie Lynn Pietranico-Cole, Montclair, NJ (US);
Nathan Robert Scott, Livingston, NJ (US);
Kshitij Chhabilbhai Thakkar, Clifton, NJ (US);
Jefferson Wright Tilley, North Caldwell, NJ (US);
Kevin Richard Guertin, Verona, NJ (US);
Hoffmann-La Roche Inc., Nutley, NJ (US);
Abstract
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.